GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avax Technologies Inc (OTCPK:AVXT) » Definitions » Return-on-Tangible-Equity

Avax Technologies (Avax Technologies) Return-on-Tangible-Equity : 0.00% (As of Sep. 2008)


View and export this data going back to . Start your Free Trial

What is Avax Technologies Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Avax Technologies's annualized net income for the quarter that ended in Sep. 2008 was $-7.48 Mil. Avax Technologies's average shareholder tangible equity for the quarter that ended in Sep. 2008 was $-1.36 Mil. Therefore, Avax Technologies's annualized Return-on-Tangible-Equity for the quarter that ended in Sep. 2008 was N/A%.

The historical rank and industry rank for Avax Technologies's Return-on-Tangible-Equity or its related term are showing as below:

AVXT's Return-on-Tangible-Equity is not ranked *
in the Biotechnology industry.
Industry Median: -47.16
* Ranked among companies with meaningful Return-on-Tangible-Equity only.

Avax Technologies Return-on-Tangible-Equity Historical Data

The historical data trend for Avax Technologies's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avax Technologies Return-on-Tangible-Equity Chart

Avax Technologies Annual Data
Trend Dec98 Dec99 Dec00 Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -155.26 -438.28 -116.35 -194.94 -382.81

Avax Technologies Quarterly Data
Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -129.75 -168.82 -338.83 -1,609.45 -

Competitive Comparison of Avax Technologies's Return-on-Tangible-Equity

For the Biotechnology subindustry, Avax Technologies's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avax Technologies's Return-on-Tangible-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avax Technologies's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Avax Technologies's Return-on-Tangible-Equity falls into.



Avax Technologies Return-on-Tangible-Equity Calculation

Avax Technologies's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2007 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2007 )  (A: Dec. 2006 )(A: Dec. 2007 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2007 )  (A: Dec. 2006 )(A: Dec. 2007 )
=-6.414/( (0.156+3.195 )/ 2 )
=-6.414/1.6755
=-382.81 %

Avax Technologies's annualized Return-on-Tangible-Equity for the quarter that ended in Sep. 2008 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Sep. 2008 )  (Q: Jun. 2008 )(Q: Sep. 2008 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Sep. 2008 )  (Q: Jun. 2008 )(Q: Sep. 2008 )
=-7.484/( (-0.438+-2.274)/ 2 )
=-7.484/-1.356
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Sep. 2008) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Avax Technologies  (OTCPK:AVXT) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Avax Technologies Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Avax Technologies's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Avax Technologies (Avax Technologies) Business Description

Traded in Other Exchanges
N/A
Address
9200 Indian Creek Parkway, Suite 200, Overland Park, KS, USA, 66210
Avax Technologies Inc is a development stage biotechnology company. The company is engaged in the development and commercialization of individualized vaccine therapies and other technologies for the treatment of cancer. It also involved in the development and commercial readiness in the immuno-oncology arena.
Executives
Carl Spana director PALATIN TECHNOLOGIES, INC., 4B CEDAR BROOK DRIVE, CRANBURY NJ 08512
Prendergast John K A director ROBERTS SHERIDAN & KOTEL, 12 EAST 49TH STREET 30TH FL, NEW YORK NY 10017

Avax Technologies (Avax Technologies) Headlines

No Headlines